Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study

UCSF Chimera—A visualization system for exploratory research and analysis

2004 • 42,136 citations

Gene Ontology: tool for the unification of biology

2000 • 38,297 citations

dbSNP: the NCBI database of genetic variation

2001 • 6,995 citations

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

2006 • 4,789 citations

EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

2005 • 3,807 citations

Drug repositioning: identifying and developing new uses for existing drugs

2004 • 2,868 citations

Oxidative stress as a mediator of apoptosis

1994 • 2,210 citations

Relating protein pharmacology by ligand chemistry

2007 • 1,915 citations

Predicting new molecular targets for known drugs

2009 • 1,599 citations

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

2009 • 1,305 citations

The Universal Protein Resource (UniProt) in 2010

2009 • 1,236 citations

Drug Target Identification Using Side-Effect Similarity

2008 • 1,200 citations

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

2005 • 1,184 citations

DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases.

2001 • 1,132 citations

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

2009 • 998 citations

Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States

1993 • 948 citations

The Universal Protein Resource (UniProt) in 2010

2010 • 943 citations

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

2010 • 862 citations

Target identification using drug affinity responsive target stability (DARTS)

2009 • 840 citations

Discovery of drug mode of action and drug repositioning from transcriptional responses

2010 • 803 citations

γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention

2001 • 757 citations

TTD: Therapeutic Target Database

2002 • 635 citations

Human protein reference database--2006 update

2005 • 605 citations

Protein promiscuity and its implications for biotechnology

2009 • 474 citations

Network analyses in systems pharmacology

2009 • 458 citations

Regulation of genes encoding NAD(P)H:quinone oxidoreductases

2000 • 419 citations

Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target

2010 • 390 citations

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

2007 • 377 citations

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

2010 • 375 citations

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

2007 • 361 citations

Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets

2010 • 333 citations

Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

2008 • 317 citations

Identifying the proteins to which small-molecule probes and drugs bind in cells

2009 • 307 citations

Elucidating mechanisms of drug-induced toxicity

2005 • 303 citations

Idiosyncratic Drug Reactions: Current Understanding

2006 • 287 citations

PDTD: a web-accessible protein database for drug target identification

2008 • 274 citations

Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses

2009 • 258 citations

Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model

2010 • 205 citations

Clozapine-induced agranulocytosis

1977 • 173 citations

Delayed drug hypersensitivity: models of T‐cell stimulation

2010 • 156 citations

Structure‐Based Approaches to Target Fishing and Ligand Profiling

2010 • 145 citations

Specific Binding of Aminoglycosides to a Human rRNA Construct Based on a DNA Polymorphism Which Causes Aminoglycoside-Induced Deafness

1997 • 142 citations

Drug Hypersensitivity Reactions: Pathomechanism and Clinical Symptoms

2010 • 135 citations

Induction of Metabolism-Dependent and -Independent Neutrophil Apoptosis by Clozapine

2000 • 131 citations

Role of systems pharmacology in understanding drug adverse events

2010 • 128 citations

Idiosyncratic drug‐induced agranulocytosis: Possible mechanisms and management

2009 • 119 citations

Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.

1997 • 111 citations

Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics

2008 • 104 citations

Harvesting Candidate Genes Responsible for Serious Adverse Drug Reactions from a Chemical-Protein Interactome

2009 • 98 citations

Multiple Active Site Corrections for Docking and Virtual Screening

2003 • 96 citations

In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators

2007 • 86 citations

Adverse Effects of Atypical Antipsychotics in the Elderly

2006 • 78 citations

Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics

2009 • 78 citations

A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir

2007 • 75 citations

Tumor Necrosis Factor Constellation Polymorphism and Clozapine-Induced Agranulocytosis in Two Different Ethnic Groups

1997 • 72 citations

Binding of Protein Kinase Inhibitors to Synapsin I Inferred from Pair-Wise Binding Site Similarity Measurements

2010 • 66 citations

The major histocompatibility complex region marked by HSP70-1 and HSP70- 2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups

1995 • 65 citations

Impact of Myeloperoxidase and NADPH-Oxidase Polymorphisms in Drug-Induced Agranulocytosis

2004 • 62 citations

Drug Adverse Reaction Target Database (DART)

2003 • 61 citations

SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome

2009 • 58 citations

NQO2 gene is associated with clozapine‐induced agranulocytosis

2003 • 55 citations

Clozapine-Induced Agranulocytosis and its Genetic Determinants

2008 • 55 citations

A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways

2010 • 52 citations

Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events

2009 • 50 citations

Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome

2010 • 50 citations

SiMMap: a web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties

2010 • 42 citations

DITOP: drug-induced toxicity related protein database

2007 • 35 citations

Computer Automated Prediction of Potential Therapeutic and Toxicity Protein Targets of Bioactive Compounds from Chinese Medicinal Plants

2002 • 30 citations

A CitationRank algorithm inheriting Google technology designed to highlight genes responsible for serious adverse drug reaction

2009 • 28 citations

Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis

1998 • 18 citations

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].

2006 • 11 citations

Personalized Medicine: the Impact on Chemistry

2010 • 10 citations